Methylmalonic Acid (MMA)
An elevated methylmalonic acid level is a highly specific marker for vitamin B12 deficiency and should prompt immediate evaluation of B12 status and initiation of replacement therapy, as it indicates functional B12 deficiency even when serum B12 levels appear normal or borderline. 1
What Elevated MMA Indicates
Elevated serum or urine MMA primarily indicates one of two conditions:
1. Vitamin B12 (Cobalamin) Deficiency
- MMA is elevated in 98.4% of patients with true B12 deficiency, making it the most specific functional marker 1
- MMA rises because B12 is required as a cofactor for methylmalonyl-CoA mutase, which converts methylmalonyl-CoA to succinyl-CoA
- Critically, 5-10% of patients with "low-normal" serum B12 levels (200-500 pg/dL) have elevated MMA, revealing occult B12 deficiency 1
- In polyneuropathy patients, 44% had B12 deficiency based solely on abnormal MMA despite normal B12 levels 1
2. Genetic Methylmalonic Acidurias
- Rare inborn errors of metabolism affecting methylmalonyl-CoA mutase or cobalamin metabolism pathways 2
- Present in infancy/childhood with severe metabolic acidosis, hyperammonemia, and neurological deterioration
- Urine MMA typically >30,000 μmol/mmol creatinine (versus <300 in nutritional deficiency) 3
3. Other Causes (Less Common)
Evaluation Algorithm
Step 1: Confirm the Elevation
- Normal MMA range: 19-76 ng/mL (or <270 nmol/L) 4
- Retest if borderline, as MMA has high biological variability (coefficient of variation 34%) 5
Step 2: Measure Serum B12
- If B12 <180 ng/L (<133 pmol/L): Confirmed B12 deficiency 6
- If B12 180-350 ng/L (133-258 pmol/L): Indeterminate - elevated MMA confirms functional deficiency 6
- If B12 >350 ng/L (>258 pmol/L): Consider other causes or rare cases of functional deficiency despite adequate levels 7
Step 3: Measure Homocysteine
- Homocysteine elevated in both B12 AND folate deficiency (95.9% sensitive for B12 deficiency) 1
- MMA is more specific - elevated in only 12.2% of isolated folate deficiency versus 98.4% in B12 deficiency 1
- If homocysteine elevated but MMA normal: suspect folate deficiency, pyridoxine deficiency, or genetic homocysteinemia 1, 8
Step 4: Assess for Confounders
Check:
- Renal function (creatinine, GFR) - renal insufficiency elevates both MMA and homocysteine 1
- Thyroid function - hypothyroidism can elevate both markers 1
- Hydration status 1
Step 5: Identify the Cause of B12 Deficiency
Key risk factors to evaluate:
- Pernicious anemia (anti-intrinsic factor antibodies, anti-parietal cell antibodies)
- Malabsorption: atrophic gastritis, gastric achlorhydria, inflammatory bowel disease (especially >20 cm ileal resection) 9
- Dietary insufficiency: vegans, vegetarians, elderly with poor intake 7
- Medications: metformin (7-11% absolute risk of deficiency), proton pump inhibitors 7
- Post-bariatric surgery (Roux-en-Y, biliopancreatic diversion) 7
Step 6: Rule Out Genetic Causes (If Applicable)
Consider genetic methylmalonic aciduria if:
- Presentation in infancy/early childhood
- Severe metabolic acidosis with hyperammonemia
- Extremely elevated urine MMA (>30,000 μmol/mmol creatinine)
- Family history or consanguinity
- Genetic testing is essential - mutations in MUT, MMAA, MMAB, MMADHC genes determine cobalamin responsiveness and treatment 3
Treatment
For Vitamin B12 Deficiency
Route selection depends on the underlying cause:
Parenteral (Intramuscular) B12 - First-Line for:
- Pernicious anemia (lack of intrinsic factor) 7
- Malabsorptive bariatric surgery (RYGB, BPD-DS) 7
- >20 cm ileal resection in Crohn's disease 9
- Clinical deficiency with neurological symptoms 9
Dosing:
- 1000 mcg IM every other day for 1 week, then monthly indefinitely 9
- This is more frequent than older 3-monthly regimens but necessary to prevent clinical manifestations 9
- For prophylaxis post-ileal resection: 1000 mcg monthly indefinitely 9
Oral B12 - Acceptable for:
- Dietary deficiency 7
- Malabsorption NOT due to intrinsic factor deficiency 7
- Metformin-induced deficiency 7
Dosing:
- 1000 mcg daily of oral crystalline cobalamin 7
- Oral route shown effective in retrospective studies (1200-2400 mcg/day) 9
For Genetic Methylmalonic Acidurias
- Hydroxocobalamin 1 mg IM daily for cobalamin-responsive forms (MMAA, MMAB, MMADHC mutations) 3
- Protein restriction, carnitine supplementation, emergency protocols 2, 3
- Genetic testing mandatory - in vivo cobalamin responsiveness testing alone is insufficient 3
- Liver transplantation considered for severe, uncontrolled cases 2
Monitoring Treatment Efficacy
- Repeat MMA levels to confirm normalization 8
- For B12 deficiency: expect improvement in hematologic parameters (if anemic), neurologic symptoms, and MMA levels
- MMA normalizes with adequate B12 replacement in nutritional deficiency 7
- In genetic forms, MMA may improve but not normalize even with intensive treatment 2
Critical Pitfalls to Avoid
Do not supplement with folate alone before confirming B12 status - folate can mask hematologic findings of B12 deficiency while allowing irreversible neurological damage to progress 8
Do not dismiss elevated MMA in patients with "normal" B12 levels - 5-10% of patients with B12 200-500 pg/dL have functional deficiency 1
Do not assume oral B12 is adequate for malabsorption - pernicious anemia, post-bariatric surgery, and significant ileal disease require parenteral replacement 7, 9
Do not rely on MMA alone in renal insufficiency - both MMA and homocysteine are elevated; clinical context is essential 1
In genetic methylmalonic aciduria, do not assume cobalamin non-responsiveness without genetic confirmation - clinical assessment alone is unreliable, and genetic testing determines appropriate hydroxocobalamin dosing 3